Gene · 7486
Papers3,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants. | J Natl Cancer Inst | 2023 | 36315097 | PubTator, text mining | PubMed |
| Germline mutations in WNK2 could be associated with serrated polyposis syndrome. | J Med Genet | 2023 | 36270769 | PubTator, text mining | PubMed |
| HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation. | Cell Mol Gastroenterol Hepatol | 2023 | 36244648 | PubTator, text mining | PubMed |
| A homozygous missense variant in the WRN gene segregating in a family with progressive pulmonary failure with recurrent spontaneous pneumothorax and interstitial lung disease. | Am J Med Genet A | 2023 | 36214313 | PubTator, text mining | PubMed |
| Peripheral neuropathies associated with DNA repair disorders. | Muscle Nerve | 2023 | 36190439 | PubTator, text mining | PubMed |
| DNA damage response signaling: A common link between cancer and cardiovascular diseases. | Cancer Med | 2023 | 36156462 | PubTator, text mining | PubMed |
| DNA damage accumulation and repair defects in FLT3-ITD acute myeloid leukemia: Implications for clonal evolution and disease progression. | Hematol Oncol | 2023 | 36131612 | PubTator, text mining | PubMed |
| Cancer carrier screening in the general population using whole-genome sequencing. | Cancer Med | 2023 | 35861108 | PubTator, text mining | PubMed |
| DNA damage and repair in age-related inflammation. | Nat Rev Immunol | 2023 | 35831609 | PubTator, text mining | PubMed |
| Roles of homologous recombination in response to ionizing radiation-induced DNA damage. | Int J Radiat Biol | 2023 | 34283012 | PubTator, text mining | PubMed |
| Multi-Faceted Roles of ERCC1-XPF Nuclease in Processing Non-B DNA Structures. | DNA (Basel) | 2022 | 40766048 | PubTator, text mining | PubMed |
| Multiregional Sequencing Analysis Reveals Extensive Genetic Heterogeneity in Gastric Tumors from Latinos. | Cancer Res Commun | 2022 | 36970058 | PubTator, text mining | PubMed |
| A CRISPR Path to Finding Vulnerabilities and Solving Drug Resistance: Targeting the Diverse Cancer Landscape and Its Ecosystem. | Adv Genet (Hoboken) | 2022 | 36911295 | PubTator, text mining | PubMed |
| SL-Cloud: A Cloud-based resource to support synthetic lethal interaction discovery. | F1000Res | 2022 | 36761837 | PubTator, text mining | PubMed |
| Innate immunity mediator STING modulates nascent DNA metabolism at stalled forks in human cells. | Front Mol Biosci | 2022 | 36710880 | PubTator, text mining | PubMed |
| Whole-exome sequencing and bioinformatic analyses revealed differences in gene mutation profiles in papillary thyroid cancer patients with and without benign thyroid goitre background. | Front Endocrinol (Lausanne) | 2022 | 36686473 | PubTator, text mining | PubMed |
| Are Alzheimer's and coronary artery diseases genetically related to longevity? | Front Psychiatry | 2022 | 36684006 | PubTator, text mining | PubMed |
| The Role of Alternative Splicing Factors, DDB2-Related Ageing and DNA Damage Repair in the Progression and Prognosis of Stomach Adenocarcinoma Patients. | Genes (Basel) | 2022 | 36672781 | PubTator, text mining | PubMed |
| PRIMPOL competes with RAD51 to resolve G-quadruplex-induced replication stress via its interaction with RPA. | Acta Biochim Biophys Sin (Shanghai) | 2022 | 36647718 | PubTator, text mining | PubMed |
| Editorial: Advances in the diagnosis and prevention of diabetic neuropathy. | Front Endocrinol (Lausanne) | 2022 | 36601016 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7486/papers?page=21